Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Non-Current Assets: 2016-2025

Historic Non-Current Assets for Anaptysbio (ANAB) over the last 9 years, with Sep 2025 value amounting to $22.4 million.

  • Anaptysbio's Non-Current Assets fell 49.82% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year decrease of 49.82%. This contributed to the annual value of $52.0 million for FY2024, which is 14.06% up from last year.
  • Latest data reveals that Anaptysbio reported Non-Current Assets of $22.4 million as of Q3 2025, which was down 48.21% from $43.3 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Non-Current Assets ranged from a high of $168.1 million in Q3 2022 and a low of $9.3 million during Q1 2021.
  • For the 3-year period, Anaptysbio's Non-Current Assets averaged around $55.7 million, with its median value being $52.0 million (2024).
  • Per our database at Business Quant, Anaptysbio's Non-Current Assets slumped by 82.54% in 2021 and then skyrocketed by 1,114.17% in 2022.
  • Quarterly analysis of 5 years shows Anaptysbio's Non-Current Assets stood at $89.2 million in 2021, then skyrocketed by 82.95% to $163.2 million in 2022, then crashed by 72.08% to $45.6 million in 2023, then grew by 14.06% to $52.0 million in 2024, then slumped by 49.82% to $22.4 million in 2025.
  • Its Non-Current Assets was $22.4 million in Q3 2025, compared to $43.3 million in Q2 2025 and $58.9 million in Q1 2025.